| Plasma cholesterol* | Plasma triglycerides* | | SAA* | | | sVCAM-1 | |
---|
| (mmol/L) | (mmol/L) | | (ug/ml) | | | (ng/ml) | |
---|
| Median | 25-75% |
n
| Median | 25-75% |
n
| Median | 25-75% |
n
| Mean | SEM |
n
|
---|
Control | 23.9 | 20-25 |
10
| 4.6 | 4.4-5.8 |
10
| 25.8 | 22.2-27.6 |
9
| 610ab | 12 |
10
|
Pd 2.6 EPS | 24.8 | 22-26 |
10
| 5.5 | 4.6-6.7 |
10
| 24.9 | 24.0-31.1 |
10
| 646a | 13 |
10
|
Pd 2.6 R | 22.0 | 21-24 |
10
| 4.3 | 3.5-5.8 |
10
| 24.7 | 20.0-29.5 |
9
| 591b | 14 |
10
|
Pd 2.6 NR | 20.2 | 16-25 |
10
| 4.3 | 3.4-5.3 |
10
| 21.5 | 20.2-26.3 |
10
| 629ab | 10 |
10
|
- SAA, serum amyloid A; sVCAM-1, soluble vascular cell adhesion molecule-1.
- Statistics were calculated using one-way ANOVA for multiple comparisons. Tukey’s test was used for pairwise comparisons of means.
- * These data failed the normality test so a Kruskal-Wallis one-way analysis of variance on the ranks was run followed by Dunn’s method for pairwise multiple comparisons. Groups with unlike superscript letters were significantly different (P < 0.05).